You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor-specific autologous lymphocyte transfer (TTRNA-xALT)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma, Diffuse Intrinsic Pontine Glioma Trial in Gainesville, Charlotte (Tumor-specific ex vivo expanded autologous

Recruiting
  • Neuroblastoma
  • Diffuse Intrinsic Pontine Glioma
  • Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)
  • Gainesville, Florida
  • +1 more
Apr 20, 2022

Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma Trial in Gainesville (TTRNA-DC vaccines with GM-CSF, TTRNA-xALT,

Recruiting
  • Diffuse Intrinsic Pontine Glioma (DIPG)
  • Brain Stem Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +5 more
  • Gainesville, Florida
    UF Health Shands Children's Hospital
Apr 29, 2022

Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)

Active, not recruiting
Has Results
  • Medulloblastoma
  • Neuroectodermal Tumor
  • TTRNA-xALT
  • TTRNA-DCs
  • Los Angeles, California
  • +2 more
Jan 7, 2022

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,

Recruiting
  • Malignant Glioma
  • High Grade Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +4 more
  • Birmingham, Alabama
  • +2 more
Feb 2, 2023

Solid Tumor Trial in Shanghai (BEN101)

Not yet recruiting
  • Solid Tumor
  • BEN101
  • Shanghai, Shanghai, China
  • +1 more
Apr 14, 2023

Advanced Melanoma, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

Recruiting
  • Advanced Melanoma
  • +3 more
  • Tumor Infiltrating Lymphocyte
  • Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

Advanced Liver Cancers, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

Recruiting
  • Advanced Liver Cancers
  • +4 more
  • Tumor Infiltrating Lymphocyte
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

Recruiting
  • HNSCC
  • +5 more
  • DP CD8 TIL
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Jun 5, 2023

Glioblastoma Multiforme, Adult Trial in Shijiazhuang (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Glioblastoma Multiforme, Adult
  • Tumor Infiltrating Lymphocytes (TIL)
  • Shijiazhuang, Hebei, China
    The Second Hospital of HeBei Medical University
Apr 11, 2022

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Surgery for harvesting tumor-draining lymph nodes
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Metastatic Uveal Melanoma
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Solid Tumor Malignancies Trial in Houston (Autologous lymphocyte infusion (ALI))

Recruiting
  • Solid Tumor Malignancies
  • Autologous lymphocyte infusion (ALI)
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Breast Cancer, Colorectal Cancer, Uveal Melanoma Trial in Orlando, Pittsburgh (TBio-4101, Pembrolizumab)

Recruiting
  • Breast Cancer
  • +2 more
  • Orlando, Florida
  • +1 more
Feb 1, 2023

Uveal Tumors, Melanoma, Uveal Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Uveal Neoplasms
  • Melanoma, Uveal
  • Tumor Infiltrating Lymphocytes (TIL)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 21, 2022

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Surgery for harvesting tumor-draining lymph nodes
  • +8 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 31, 2023

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023

Solid Tumor Trial in Tianjin (LM103)

Recruiting
  • Solid Tumor
  • LM103
  • Tianjin, China
    Tianjin Beichen Hospital
Jul 4, 2023

Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

Active, not recruiting
  • Metastatic Melanoma
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

Recruiting
  • Gastric Cancer
  • +9 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Fludarabine + Cyclophosphamide combination
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 21, 2022

Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)

Active, not recruiting
  • Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 28, 2022

Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)

Not yet recruiting
  • Head and Neck Cancer
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Oct 18, 2023

Adult Trial in Zhengzhou (GT101)

Recruiting
  • Adult
  • GT101
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Oct 11, 2023

Solid Tumor Trial in China (GT201)

Recruiting
  • Solid Tumor
  • GT201
  • Zhengzhou, Henan, China
  • +4 more
Feb 6, 2023